TARA DEVOY: Open Payments
NPI 1801184684 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 28 payments from 11 companies in 2025. Trend: 2023 $455 · 2024 $319 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $248 |
| E.R. Squibb & Sons, L.L.C. | 5 | $178 |
| Lilly USA, LLC | 3 | $63 |
| PFIZER INC. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 1 | $27 |
| Boston Scientific Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: JARDIANCE, ZEPBOUND, VYNDAQEL, ONPATTRO, CAMZYOS, FARXIGA, Wegovy, ENTRESTO.
Industry payments across PA — which companies pay providers there.
